The store will not work correctly when cookies are disabled.
3-[6-Amino-5-(4-chlorophenyl)pyridin-3-yl]benzoic acid
ID: ALA4740781
PubChem CID: 162645224
Max Phase: Preclinical
Molecular Formula: C18H13ClN2O2
Molecular Weight: 324.77
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Nc1ncc(-c2cccc(C(=O)O)c2)cc1-c1ccc(Cl)cc1
Standard InChI: InChI=1S/C18H13ClN2O2/c19-15-6-4-11(5-7-15)16-9-14(10-21-17(16)20)12-2-1-3-13(8-12)18(22)23/h1-10H,(H2,20,21)(H,22,23)
Standard InChI Key: LGCYIFSJNVXNBT-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 25 0 0 0 0 0 0 0 0999 V2000
16.4951 -14.5113 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4940 -15.3308 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2020 -15.7398 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.9117 -15.3304 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.9088 -14.5077 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2002 -14.1024 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.6165 -15.7371 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6165 -16.5554 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3240 -16.9628 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0320 -16.5530 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0281 -15.7316 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3200 -15.3279 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6150 -14.0964 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.7409 -16.9596 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
15.7878 -15.7392 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0802 -15.3283 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3726 -15.7356 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3715 -16.5537 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0839 -16.9627 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7885 -16.5530 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6624 -15.3263 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6635 -14.5091 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.9542 -15.7340 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 7 1 0
4 7 1 0
5 13 1 0
10 14 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 15 1 0
2 15 1 0
21 22 1 0
21 23 2 0
17 21 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 324.77 | Molecular Weight (Monoisotopic): 324.0666 | AlogP: 4.35 | #Rotatable Bonds: 3 |
Polar Surface Area: 76.21 | Molecular Species: ACID | HBA: 3 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 2.98 | CX Basic pKa: 7.01 | CX LogP: 2.38 | CX LogD: 1.86 |
Aromatic Rings: 3 | Heavy Atoms: 23 | QED Weighted: 0.75 | Np Likeness Score: -0.58 |
References
1. Dow RL,Ammirati M,Bagley SW,Bhattacharya SK,Buckbinder L,Cortes C,El-Kattan AF,Ford K,Freeman GB,Guimarães CRW,Liu S,Niosi M,Skoura A,Tess D. (2018) 2-Aminopyridine-Based Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 (MAP4K4) Inhibitors: Assessment of Mechanism-Based Safety., 61 (7): [PMID:29570292] [10.1021/acs.jmedchem.8b00152] |